Sugi Predict

Sugi Predict / Compounds / SCHEMBL201390

SCHEMBL201390

SCHEMBL201390

C[C@@](N)(CCCCN)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ARG1 P05089 2/20 0.62
▸ ARG2 P78540 2/20 0.62
▸ GGT1 P19440 1/20 0.52
▸ ODC1 P11926 2/20 0.45
▸ BLM P54132 4/20 0.42
▸ LMNA P02545 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP2D6 P10635 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.39
▸ THRB P10828 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ PLG P00747 1/20 0.39
▸ ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574473 1.00 ARG1 (0.62) ARG1ARG2GGT1ODC1BLM
SCHEMBL161423 1.00 ARG1 (0.62) ARG1ARG2GGT1ODC1BLM
SCHEMBL23733387 0.98 ARG1 (0.60) ARG1ARG2GGT1ODC1BLM
SCHEMBL5320545 0.98 ARG1 (0.60) ARG1ARG2GGT1ODC1BLM
SCHEMBL5325205 0.98 ARG1 (0.60) ARG1ARG2GGT1ODC1BLM
SCHEMBL162369 0.93 ARG1 (0.59) ARG1ARG2GGT1ODC1BLM
SCHEMBL162370 0.93 ARG1 (0.59) ARG1ARG2GGT1ODC1BLM
SCHEMBL574141 0.93 ARG1 (0.59) ARG1ARG2GGT1ODC1BLM
Hydrochloric Acid SCHEMBL3219766 0.91 ARG1 (0.57) ARG1ARG2GGT1ODC1BLM
Water SCHEMBL7726696 0.91 ARG1 (0.57) ARG1ARG2GGT1ODC1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1986 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092091-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS Humanwell Pharmaceutical US 2025-03-20 — — US claimed
CN-114615976-A Kappa opioid receptor peptide amide agonists 人福医药美国公司 2022-06-10 — — CN claimed
WO-2021026492-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS Humanwell Pharmaceutical US (US) 2021-02-11 — — WO claimed
US-20210040150-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) 2021-02-11 — — US claimed
EP-2114428-B1 Triazole linked macrocyclic peptides AILERON THERAPEUTICS INC (US) 2012-10-31 — — EP claimed
US-20090215895-A1 Therapeutic and carrier molecules PEPLIN BIOLIPIDS PTY LTD (AU) 2009-08-27 — — US claimed
EP-1718602-A4 THERAPEUTIC AND CARRIER MOLECULES PEPLIN BIOLIPIDS PTY LTD (AU) 2007-12-12 — — EP claimed
US-20070197430-A1 Conjugates And Therapeutic Uses Thereof THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-08-23 — — US claimed
US-7256172-B1 Method of treatment and agents useful for same THE UNIVERSITY OF MELBOURNE (AU) 2007-08-14 — — US claimed
EP-1781689-A1 CONJUGATES AND THERAPEUTIC USES THEREOF The Walter and Eliza Hall Institute of Medical Research (AU) 2007-05-09 — — EP claimed
US-20070032417-A1 Peptides and therapeutic uses thereof WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-02-08 — — US claimed
EP-1718602-A1 THERAPEUTIC AND CARRIER MOLECULES Peplin Biolipids Pty Ltd. (AU) 2006-11-08 — — EP claimed
US-7070969-B1 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis THE UNIVERSITY OF QUEENSLAND (AU) 2006-07-04 — — US claimed
WO-2006000034-A1 CONJUGATES AND THERAPEUTIC USES THEREOF THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2006-01-05 — — WO claimed
WO-2005073164-A1 THERAPEUTIC AND CARRIER MOLECULES PEPLIN BIOLIPIDS PTY LTD (AU) 2005-08-11 — — WO claimed
WO-2004058804-A1 PEPTIDES AND THERAPEUTIC USES THEREOF WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2004-07-15 — — WO claimed
CN-122094704-A Formulations for oral administration of active agents comprising a combination of acid-neutralizing polymer and non-polymeric material — 2026-05-26 — — CN disclosed
WO-2026085582-A1 PROTEIN CAGES THE UNIVERSITY OF SYDNEY (AU) 2026-04-30 — — WO disclosed
WO-1994011388-A1 SUPPORT FOR THE SYNTHESIS OF MODULAR POLYMERS CHIRON MIMOTOPES PTY. LTD. (AU) 1994-05-26 — — WO disclosed
WO-1994003483-A1 ENDOTHELIN RECEPTOR-BINDING COMPOUNDS CHIRON CORPORATION (US) 1994-02-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215895-A1 Therapeutic and carrier molecules PHKG1, PHKG2, DGKB ARG1 4434/4885ARG2 2829/4885GGT1 1211/4885
US-20070032417-A1 Peptides and therapeutic uses thereof BCL2, BAX, BCL2L13 ARG1 2160/4885ARG2 223/4885GGT1 1067/4885
US-20250092091-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS OPRK1, OPRL1, OPRD1 ARG1 896/4885ARG2 1850/4885GGT1 3345/4885
US-20070197430-A1 Conjugates And Therapeutic Uses Thereof BCL2, BAX, BAD ARG1 2897/4885ARG2 285/4885GGT1 315/4885
US-20210040150-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS OPRK1, OPRL1, OPRD1 ARG1 809/4885ARG2 1722/4885GGT1 3288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.